Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TER vs GSK✓SelectedUSD · GSKTER vs GSK performance historyLatest closeAs of-5.38%11/13
Stock and ETF performance explorer

TER vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+191.2%
GSK return
+65.8%
Excess return
+125.4%
Maximum drawdown
-58.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.4%+0.5%-5.9%-5.5%
7D+14.4%+1.1%+13.2%+14.1%
30D-30.6%+6.3%-36.9%-31.4%
3M-39.2%+1.8%-41.0%-39.6%
6M-31.3%+1.7%-32.9%-32.6%
YTD+29.1%+6.5%+22.5%+26.2%
1Y+47.4%+9.5%+37.9%+42.9%
3Y+191.2%+65.3%+125.9%+162.5%
All+191.2%+65.8%+125.4%+162.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling